000298999 001__ 298999
000298999 005__ 20250416160615.0
000298999 0247_ $$2doi$$a10.1016/j.annonc.2024.11.010
000298999 0247_ $$2pmid$$apmid:39984357
000298999 0247_ $$2ISSN$$a0923-7534
000298999 0247_ $$2ISSN$$a1569-8041
000298999 037__ $$aDKFZ-2025-00409
000298999 041__ $$aEnglish
000298999 082__ $$a610
000298999 1001_ $$aMosele, M. F.$$b0
000298999 245__ $$aCorrigendum to 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group': [Ann Oncol 35 (2024) 588-606].
000298999 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2025
000298999 3367_ $$2DRIVER$$aarticle
000298999 3367_ $$2DataCite$$aOutput Types/Journal article
000298999 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1744812335_25114$$xErratum/Correction
000298999 3367_ $$2BibTeX$$aARTICLE
000298999 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000298999 3367_ $$00$$2EndNote$$aJournal Article
000298999 500__ $$aVolume 36, Issue 4, April 2025, Page 472
000298999 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000298999 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000298999 7001_ $$aWestphalen, C. B.$$b1
000298999 7001_ $$aStenzinger, A.$$b2
000298999 7001_ $$aBarlesi, F.$$b3
000298999 7001_ $$aBayle, A.$$b4
000298999 7001_ $$aBièche, I.$$b5
000298999 7001_ $$aBonastre, J.$$b6
000298999 7001_ $$aCastro, E.$$b7
000298999 7001_ $$aDienstmann, R.$$b8
000298999 7001_ $$0P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aKrämer, Alwin$$b9$$udkfz
000298999 7001_ $$aCzarnecka, A. M.$$b10
000298999 7001_ $$aMeric-Bernstam, F.$$b11
000298999 7001_ $$aMichiels, S.$$b12
000298999 7001_ $$aMiller, R.$$b13
000298999 7001_ $$aNormanno, N.$$b14
000298999 7001_ $$aReis-Filho, J.$$b15
000298999 7001_ $$aRemon, J.$$b16
000298999 7001_ $$aRobson, M.$$b17
000298999 7001_ $$aRouleau, E.$$b18
000298999 7001_ $$aScarpa, A.$$b19
000298999 7001_ $$aSerrano, C.$$b20
000298999 7001_ $$aMateo, J.$$b21
000298999 7001_ $$aAndré, F.$$b22
000298999 773__ $$0PERI:(DE-600)2003498-2$$a10.1016/j.annonc.2024.11.010$$gp. S0923753424049470$$n4$$p472$$tAnnals of oncology$$v36$$x0923-7534$$y2025
000298999 909CO $$ooai:inrepo02.dkfz.de:298999$$pVDB
000298999 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)493c5fbf69f1b20df6f048712f3ad4a0$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000298999 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000298999 9141_ $$y2025
000298999 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bANN ONCOL : 2022$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-07
000298999 915__ $$0StatID:(DE-HGF)9950$$2StatID$$aIF >= 50$$bANN ONCOL : 2022$$d2025-01-07
000298999 9201_ $$0I:(DE-He78)A360-20160331$$kA360$$lKKE Mol. Hämatologie/Onkologie$$x0
000298999 980__ $$ajournal
000298999 980__ $$aVDB
000298999 980__ $$aI:(DE-He78)A360-20160331
000298999 980__ $$aUNRESTRICTED